TB-500 application enhances integrin-mediated cell attachment to extracellular matrix components, with quantifiable increases in adhesion strength measured through centrifugal force resistance protocols
Species differences in peptide metabolism, receptor density, and clearance pathways mean that a compound safe in rats could, in theory, produce unexpected toxicity in humans
Here the target is the gut the intestinal mucosa, the epithelial lining, or the enteric immune system
Side effects were however recorded from use of these compounds on laboratory rats
As such, it might cause some hormonal imbalances leading to mood swings or other emotional responses
Always consult with a qualified healthcare provider before starting any new therapy, including peptide treatments.